IRIS PubliCatt

Fagotti, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.584
EU - Europa 6.450
AS - Asia 1.191
AF - Africa 63
SA - Sud America 38
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 11
Totale 15.355
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.545
SE - Svezia 1.620
DE - Germania 1.573
IT - Italia 1.085
CN - Cina 796
IE - Irlanda 553
UA - Ucraina 393
PL - Polonia 355
FR - Francia 328
GB - Regno Unito 187
IN - India 161
FI - Finlandia 131
TR - Turchia 64
BE - Belgio 54
CI - Costa d'Avorio 47
IR - Iran 35
NL - Olanda 33
JP - Giappone 29
CA - Canada 25
HK - Hong Kong 25
RU - Federazione Russa 18
SG - Singapore 18
CH - Svizzera 17
ES - Italia 17
AU - Australia 15
CZ - Repubblica Ceca 15
RO - Romania 15
BR - Brasile 14
AT - Austria 11
BZ - Belize 11
EU - Europa 9
HR - Croazia 9
CL - Cile 8
KR - Corea 7
OM - Oman 7
EG - Egitto 6
SA - Arabia Saudita 6
VN - Vietnam 6
ID - Indonesia 5
MY - Malesia 5
PH - Filippine 5
PT - Portogallo 5
AR - Argentina 4
GR - Grecia 4
IL - Israele 4
MD - Moldavia 4
PE - Perù 4
BD - Bangladesh 3
BG - Bulgaria 3
DK - Danimarca 3
EC - Ecuador 3
EE - Estonia 3
HU - Ungheria 3
LT - Lituania 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
GF - Guiana Francese 2
LA - Repubblica Popolare Democratica del Laos 2
LI - Liechtenstein 2
LK - Sri Lanka 2
MA - Marocco 2
MX - Messico 2
NG - Nigeria 2
ZA - Sudafrica 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
ET - Etiopia 1
IQ - Iraq 1
MK - Macedonia 1
MT - Malta 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
TW - Taiwan 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 15.355
Salva come PNG Salva come JPEG
Città #
Chandler 1.962
Ashburn 690
Dublin 547
San Mateo 347
Warsaw 339
Wilmington 252
Jacksonville 246
Ann Arbor 239
New York 232
Boston 222
Rome 195
Nanjing 185
Princeton 184
Houston 157
Beijing 156
Fairfield 155
Marseille 155
Milan 153
Woodbridge 153
Dearborn 119
Nürnberg 105
Redwood City 91
Seattle 89
Cattolica 86
Lawrence 73
Nanchang 59
Bremen 55
Brussels 48
Abidjan 47
Mountain View 46
Izmir 45
Kunming 45
Cambridge 43
Norwalk 43
Boardman 41
Leawood 41
Hangzhou 36
Fuzhou 35
Helsinki 35
Hebei 31
Los Angeles 31
Shenyang 30
Zhengzhou 30
Augusta 29
Oggiono 28
Changsha 27
University Park 26
Pune 25
Redmond 24
Lancaster 22
Amsterdam 21
Andover 20
Washington 20
Munich 18
Busto Arsizio 17
Tianjin 17
Chicago 16
Hefei 16
Jiaxing 16
Detroit 15
Fremont 15
Lappeenranta 15
Ardabil 14
Edinburgh 14
San Jose 14
San Francisco 13
Genazzano 12
Hong Kong 12
London 12
Naples 12
Salò 12
Shanghai 12
Toronto 12
Belize City 11
Clearwater 11
Guangzhou 11
Bari 10
Buffalo 10
Falls Church 10
Jinan 10
Orange 10
Changchun 9
Kraków 9
Tokyo 9
Vienna 9
Brno 8
Frankfurt am Main 8
Kish 8
Zagreb 8
Bern 7
Costa Mesa 7
Florence 7
Gunzenhausen 7
Lanzhou 7
Menlo Park 7
Phoenix 7
Sacramento 7
San Diego 7
Wuhan 7
Antalya 6
Totale 8.626
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 789
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 303
Laparoendoscopic Single-Site Surgery (LESS) for Treatment of Benign Adnexal Disease: Single-Center Experience Over 3-Years 298
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 241
Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials. 231
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 226
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 161
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 156
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 156
Total laparoscopic hysterectomy in early-stage endometrial cancer using an intrauterine manipulator: is it a bias for frozen section analysis? Case-control study 140
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 140
Delaying surgery for patients with a previous SARS-CoV-2 infection 140
Advanced vulvar carcinoma: is it worth operating? A perioperative management protocol for radical and reconstructive surgery 137
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 131
Urologic surgery in gynecologic oncology: a large single-institution experience 129
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 125
Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes 123
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 123
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 121
The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. 117
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 117
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 109
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 109
Teaching and training in laparoscopic surgery: experience of Catholic Laparoscopy Advanced Surgery School in the basic gynecological surgery 107
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 107
Importance of a specialized pathologist for the examination of frozen sections of adnexal masses. 106
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 105
Sexual and reproductive outcomes in early stage cervical cancer patients after excisional cone as a fertility-sparing surgery: An italian experience 101
Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery 99
Risk of postoperative pelvic abscess in major gynecologic oncology surgery: one-year single-institution experience 98
Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer 96
Ultrasound evaluation of intra-abdominal sites of disease to predict the likelihood of suboptimal cytoreduction in advanced ovarian cancer: a propective study 95
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study 94
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 83
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial 81
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 80
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): A feasibility study 80
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 79
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome 77
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 75
Targeting the hallmarks of ovarian cancer: The big picture 75
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 75
Excisional cone as fertility-sparing treatment in early-stage cervical cancer. 73
Telelap ALF-X vs Standard Laparoscopy for the Treatment of Early-Stage Endometrial Cancer: A Single-Institution Retrospective Cohort Study 73
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 73
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 73
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer 72
Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience 72
Fusion imaging in the preoperative assessment of the extension of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings 72
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 71
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 71
Perioperative outcomes of laparoendoscopic single-site surgery (LESS) versus conventional laparoscopy for adnexal disease: a case--control study 70
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 70
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data 70
Systematic pelvic and aortic lymphadenectomy in advanced ovarian cancer patients at the time of interval debulking surgery: a double-institution case-control study 68
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer 68
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 66
Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications 66
Resectability and Vascular Management of Retroperitoneal Gynecological Malignancies: A Large Single-institution Case-Series 66
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 66
Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients 66
Robotic treatment of colorectal endometriosis: technique, feasibility and short-term results 65
The new robotic TELELAP ALF-X in gynecological surgery: single-center experience 65
Role of Intraoperative Ultrasound to Extend the Application of Minimally Invasive Surgery for Treatment of Recurrent Gynecologic Cancer 65
Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications 65
Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study 65
Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back 65
Molecular profile of brca-negative long survivor high grade serous ovarian cancer patients using a somatic multigene panel 65
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases 64
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments 64
Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: Proof of a concept 62
Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer. 62
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 62
Neoadjuvant chemoradiation followed by radical hysterectomy in FIGO Stage IIIB cervical cancer: feasibility, complications, and clinical outcome. 61
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 61
Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer 61
Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature 61
BRCA testing delay during the COVID-19 pandemic: How to act? 61
Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience 60
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 59
The role of liquid based cytology and ancillary techniques in the peritoneal washing analysis: Our institutional experience 58
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case Matched Control Study 58
Feasibility of tumor testing for BRCA status in high-grade serous ovarian cancer using fresh-frozen tissue based approach 58
Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study 57
Sentinel lymph node detection in endometrial cancer with indocyanine green: laparoscopic versus robotic approach 57
Long-term evaluation of quality of life and gastrointestinal well-being after segmental colo-rectal resection for deep infiltrating endometriosis (ENDO-RESECT QoL) 56
Peritoneal Hpv-Dna Test In Cervical Cancer (Pioneer Study): A Proof Of Concept 56
Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience 56
Prognostic Significance of Ultrasound Characteristics and Body Mass Index in Patients with Apparent Early-Stage Cervical Cancer: A Single-Center, Retrospective, Cohort Study 55
[Prevention of postoperative abdominal adhesions in gynecological surgery. Consensus paper of an Italian gynecologists' task force on adhesions] 55
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 55
Additional molecular and clinical evidence open the way to definitive IARC classification of the BRCA1 c.5332G > A (p.Asp1778Asn) variant 55
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 55
Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations 54
Radical hysterectomy after chemoradiation in FIGO stage III cervical cancer patients versus chemoradiation and brachytherapy: Complications and 3-years survival 54
Laparoscopic intraoperative ultrasound-guided excision with laparoscopic probe in fertility sparing surgery of borderline ovarian tumor recurrence 54
Arterial-enteric fistula after pelvic lymphadenectomy in secondary cytoreductive surgery for recurrent ovarian cancer 54
Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis 54
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer 54
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study 53
Totale 9.662
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.197
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.197
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019150 0 0 0 0 0 0 0 0 0 0 98 52
2019/20201.953 264 96 95 104 114 192 254 122 209 154 226 123
2020/20211.692 113 136 227 117 201 59 185 50 167 114 272 51
2021/20222.400 146 96 30 254 90 55 91 389 112 139 426 572
2022/20235.444 710 695 441 738 357 710 272 377 673 94 234 143
2023/20242.371 113 839 99 264 97 360 221 117 62 193 6 0
Totale 16.286